Position in TARS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,778,926
+$1,119,107 QoQ
Shares Held
44,152
+86.6% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#85
of 256 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $612,941,942 across 144 Biotechnology names. TARS ranks #62 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | TWST |
Twist Bioscience Corp
|
255,271 | $26,262,280 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 7 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 |
All Filings in TARS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,778,926 | 44,152 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,659,819 | 23,661 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,466,226 | 54,546 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,188,837 | 20,004 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,833,218 | 94,624 | Shares | Sole | 2025-08-12 | |
| 2024-06-30 | $948,663 | 34,903 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,491,731 | 41,038 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $799,814 | 39,497 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||